Howmedica Is Sole Remaining Pfizer Device Business Following AMS Sale
This article was originally published in The Gray Sheet
Executive Summary
Pfizer's proposed $130 mil. sale of its American Medical Systems urological products business to the investment firm of E.M. Warburg, Pincus & Co., announced July 22, leaves the Howmedica orthopedics business the sole remaining unit of the Pfizer medical technology group.